Global Erectile Dysfunction Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 01-Aug-2019
No. of pages: 118
Inquire Before Buying

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.

The global Erectile Dysfunction Drugs market is valued at 5042.6 million US$ in 2018 and will reach 6583.3 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Erectile Dysfunction Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Erectile Dysfunction Drugs in key regions like North America, Europe, China, South Korea and Israel, focuses on the consumption of Erectile Dysfunction Drugs in these regions.

This research report categorizes the global Erectile Dysfunction Drugs market by top players/brands, region, type and end user. This report also studies the global Erectile Dysfunction Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Eli Lilly

- Pfizer

- Bayer

- BaiYunShan General Factory

- S.K. Chemicals

- Teva Pharma

- Dong-A ST

- Metuchen Pharma

- Seoul Pharma

- CSBIO.

Erectile Dysfunction Drugs market size by Type

- Sildenafil

- Tadalafil

- Others

In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Erectile Dysfunction Drugs market size by Applications

- Hospital Pharmacies

- Private Clinics

- Retail Pharmacies

- E-Commerce (B2B)

- E-Commerce (B2C)

In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Central & South America

- - Brazil

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Erectile Dysfunction Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Erectile Dysfunction Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Erectile Dysfunction Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Erectile Dysfunction Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Erectile Dysfunction Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Pill). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Erectile Dysfunction Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Erectile Dysfunction Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type
1.4.2 Sildenafil
1.4.3 Tadalafil
1.4.4 Others
1.5 Market by Application
1.5.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Retail Pharmacies
1.5.5 E-Commerce (B2B)
1.5.6 E-Commerce (B2C)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Drugs Market Size
2.1.1 Global Erectile Dysfunction Drugs Revenue 2014-2025
2.1.2 Global Erectile Dysfunction Drugs Sales 2014-2025
2.2 Erectile Dysfunction Drugs Growth Rate by Regions
2.2.1 Global Erectile Dysfunction Drugs Sales by Regions
2.2.2 Global Erectile Dysfunction Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Erectile Dysfunction Drugs Sales by Manufacturers
3.1.1 Erectile Dysfunction Drugs Sales by Manufacturers
3.1.2 Erectile Dysfunction Drugs Sales Market Share by Manufacturers
3.2 Erectile Dysfunction Drugs Revenue by Manufacturers
3.2.1 Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Erectile Dysfunction Drugs Price by Manufacturers
3.4 Erectile Dysfunction Drugs Manufacturing Base Distribution, Product Types
3.4.1 Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erectile Dysfunction Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Erectile Dysfunction Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type
4.2 Global Erectile Dysfunction Drugs Revenue by Type
4.3 Erectile Dysfunction Drugs Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Erectile Dysfunction Drugs Breakdown Data by Application
6 North America
6.1 North America Erectile Dysfunction Drugs by Country
6.1.1 North America Erectile Dysfunction Drugs Sales by Country
6.1.2 North America Erectile Dysfunction Drugs Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Erectile Dysfunction Drugs by Type
6.3 North America Erectile Dysfunction Drugs by Application
7 Europe
7.1 Europe Erectile Dysfunction Drugs by Country
7.1.1 Europe Erectile Dysfunction Drugs Sales by Country
7.1.2 Europe Erectile Dysfunction Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Erectile Dysfunction Drugs by Type
7.3 Europe Erectile Dysfunction Drugs by Application
8 Asia Pacific
8.1 Asia Pacific Erectile Dysfunction Drugs by Region
8.1.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region
8.1.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Erectile Dysfunction Drugs by Type
8.3 Asia Pacific Erectile Dysfunction Drugs by Application
9 Central & South America
9.1 Central & South America Erectile Dysfunction Drugs by Country
9.1.1 Central & South America Erectile Dysfunction Drugs Sales by Country
9.1.2 Central & South America Erectile Dysfunction Drugs Revenue by Country
9.1.3 Brazil
9.2 Central & South America Erectile Dysfunction Drugs by Type
9.3 Central & South America Erectile Dysfunction Drugs by Application
10 Middle East and Africa
10.1 Middle East and Africa Erectile Dysfunction Drugs by Country
10.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country
10.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Erectile Dysfunction Drugs by Type
10.3 Middle East and Africa Erectile Dysfunction Drugs by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Company Business Overview
11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Eli Lilly Erectile Dysfunction Drugs Products Offered
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Erectile Dysfunction Drugs Products Offered
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Erectile Dysfunction Drugs Products Offered
11.3.5 Bayer Recent Development
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Details
11.4.2 Company Business Overview
11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
11.4.5 BaiYunShan General Factory Recent Development
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Company Details
11.5.2 Company Business Overview
11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
11.5.5 S.K. Chemicals Recent Development
11.6 Teva Pharma
11.6.1 Teva Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Pharma Erectile Dysfunction Drugs Products Offered
11.6.5 Teva Pharma Recent Development
11.7 Dong-A ST
11.7.1 Dong-A ST Company Details
11.7.2 Company Business Overview
11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Dong-A ST Erectile Dysfunction Drugs Products Offered
11.7.5 Dong-A ST Recent Development
11.8 Metuchen Pharma
11.8.1 Metuchen Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
11.8.5 Metuchen Pharma Recent Development
11.9 Seoul Pharma
11.9.1 Seoul Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Seoul Pharma Erectile Dysfunction Drugs Products Offered
11.9.5 Seoul Pharma Recent Development
11.10 CSBIO.
11.10.1 CSBIO. Company Details
11.10.2 Company Business Overview
11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 CSBIO. Erectile Dysfunction Drugs Products Offered
11.10.5 CSBIO. Recent Development
12 Future Forecast
12.1 Erectile Dysfunction Drugs Market Forecast by Regions
12.1.1 Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025
12.2 Erectile Dysfunction Drugs Market Forecast by Type
12.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Type 2019-2025
12.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type 2019-2025
12.3 Erectile Dysfunction Drugs Market Forecast by Application
12.4 North America Erectile Dysfunction Drugs Forecast
12.5 Europe Erectile Dysfunction Drugs Forecast
12.6 Asia Pacific Erectile Dysfunction Drugs Forecast
12.7 Central & South America Erectile Dysfunction Drugs Forecast
12.8 Middle East and Africa Erectile Dysfunction Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erectile Dysfunction Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Erectile Dysfunction Drugs Product Picture
Table Erectile Dysfunction Drugs Market Segments
Table Key Manufacturers Erectile Dysfunction Drugs Covered
Table Global Erectile Dysfunction Drugs Market Size Growth Rate by Type 2019-2025 (M Pill) & (Million US$)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Type in 2018 & 2025
Figure Sildenafil Product Picture
Table Major Manufacturers of Sildenafil
Figure Tadalafil Product Picture
Table Major Manufacturers of Tadalafil
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Erectile Dysfunction Drugs Market Size Growth Rate by Application 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs 4900 Sales Market Share by Application in 2018
Figure Hospital Pharmacies
Figure Private Clinics
Figure Retail Pharmacies
Figure E-Commerce (B2B)
Figure E-Commerce (B2C)
Figure Erectile Dysfunction Drugs Report Years Considered
Figure Global Erectile Dysfunction Drugs Market Size 2014-2025 (Million US$)
Figure Global Erectile Dysfunction Drugs Sales 2014-2025 (M Pill)
Table Global Erectile Dysfunction Drugs Market Size by Regions 2014-2019 (M Pill) & (Million US$)
Table Global Erectile Dysfunction Drugs Sales by Regions 2014-2019 (M Pill)
Table Global Erectile Dysfunction Drugs Sales Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Erectile Dysfunction Drugs Sales Market Share by Regions
Table Global Erectile Dysfunction Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Erectile Dysfunction Drugs Revenue Market Share by Regions
Table Global Erectile Dysfunction Drugs Sales by Manufacturers (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
Figure Erectile Dysfunction Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Erectile Dysfunction Drugs Price (2014-2019) (USD/Pill)
Table Erectile Dysfunction Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Erectile Dysfunction Drugs Product Type
Table Date of International Manufacturers Enter into Erectile Dysfunction Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Type in 2018
Table Global Erectile Dysfunction Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Type in 2018
Table Erectile Dysfunction Drugs Price by Type 2014-2019 (USD/Pill)
Table Global Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Application (2014-2019)
Figure Global Sales Erectile Dysfunction Drugs Market Share by Application (2014-2019)
Figure Global Sales Erectile Dysfunction Drugs Market Share by Application in 2018
Figure North America Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure North America Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Erectile Dysfunction Drugs Sales by Country (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Country (2014-2019)
Figure 2018 North America Erectile Dysfunction Drugs Sales Market Share by Country
Table North America Erectile Dysfunction Drugs Revenue by Country (2014-2019) (Million US$)
Table North America Erectile Dysfunction Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 North America Erectile Dysfunction Drugs Revenue Market Share by Country
Figure United States Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure United States Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Canada Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Mexico Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure 2018 North America Erectile Dysfunction Drugs Market Share by Type
Table North America Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure 2018 North America Erectile Dysfunction Drugs Market Share by Application
Figure Europe Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Europe Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Erectile Dysfunction Drugs Sales by Country (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Europe Erectile Dysfunction Drugs Sales Market Share by Country
Table Europe Erectile Dysfunction Drugs Revenue by Country (2014-2019) (Million US$)
Table Europe Erectile Dysfunction Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Erectile Dysfunction Drugs Revenue Market Share by Country
Figure Germany Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Germany Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure France Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure UK Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Italy Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Russia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Europe Erectile Dysfunction Drugs Market Share by Type
Table Europe Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Europe Erectile Dysfunction Drugs Market Share by Application
Figure Asia Pacific Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Asia Pacific Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Sales by Region (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region
Table Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Country
Figure China Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure China Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Japan Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure South Korea Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure India Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Australia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Indonesia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Thailand Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Malaysia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Philippines Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Vietnam Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Erectile Dysfunction Drugs Market Share by Type
Table Asia Pacific Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Erectile Dysfunction Drugs Market Share by Application
Figure Central & South America Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Central & South America Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Erectile Dysfunction Drugs Sales by Country (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Erectile Dysfunction Drugs Sales Market Share by Country
Table Central & South America Erectile Dysfunction Drugs Revenue by Country (2014-2019) (Million US$)
Table Central & South America Erectile Dysfunction Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Erectile Dysfunction Drugs Revenue Market Share by Country
Figure Brazil Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Brazil Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Erectile Dysfunction Drugs Market Share by Type
Table Central & South America Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Erectile Dysfunction Drugs Market Share by Application
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country
Table Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country
Figure Turkey Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Turkey Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure GCC Countries Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Egypt Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure South Africa Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Erectile Dysfunction Drugs Market Share by Type
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Erectile Dysfunction Drugs Market Share by Application
Table Eli Lilly Company Details
Table Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Pfizer Company Details
Table Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table BaiYunShan General Factory Company Details
Table BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table BaiYunShan General Factory Recent Development
Table S.K. Chemicals Company Details
Table S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table S.K. Chemicals Recent Development
Table Teva Pharma Company Details
Table Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Teva Pharma Recent Development
Table Dong-A ST Company Details
Table Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Dong-A ST Recent Development
Table Metuchen Pharma Company Details
Table Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Metuchen Pharma Recent Development
Table Seoul Pharma Company Details
Table Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table Seoul Pharma Recent Development
Table CSBIO. Company Details
Table CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2014-2019)
Table CSBIO. Recent Development
Table Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025 (M Pill)
Table Global Erectile Dysfunction Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Erectile Dysfunction Drugs Sales Forecast by Type 2019-2025 (M Pill)
Table Global Erectile Dysfunction Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Erectile Dysfunction Drugs Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Type 2019-2025
Table Global Erectile Dysfunction Drugs Sales Forecast by Application 2019-2025 (M Pill)
Table Global Erectile Dysfunction Drugs Sales Market Share Forecast by Application 2019-2025
Figure North America Erectile Dysfunction Drugs Sales Growth Rate Forecast (2019-2025) (M Pill)
Figure North America Erectile Dysfunction Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Erectile Dysfunction Drugs Sales Growth Rate Forecast (2019-2025) (M Pill)
Figure Europe Erectile Dysfunction Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Erectile Dysfunction Drugs Sales Growth Rate Forecast (2019-2025) (M Pill)
Figure Asia Pacific Erectile Dysfunction Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Erectile Dysfunction Drugs Sales Growth Rate Forecast (2019-2025) (M Pill)
Figure Central & South America Erectile Dysfunction Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Growth Rate Forecast (2019-2025) (M Pill)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Erectile Dysfunction Drugs Value Chain
Table Erectile Dysfunction Drugs Customers List
Figure Channels of Distribution
Table Erectile Dysfunction Drugs Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Testosterone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period. The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
  • Global Finasteride Tablets Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Global Erectile Dysfunction Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
  • Global Methyltestosterone Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 75
    The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles......
  • Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Tamsulosin market: According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
  • Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Erectile Dysfunction Drug market: According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Finasteride Tablets market: According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
  • Finasteride Tablets - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 106
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
  • Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 134
    Report Overview: The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period. This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs